Market Overview

Recap: ShockWave Medical Q3 Earnings


Shares of ShockWave Medical (NASDAQ:SWAV) were flat in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 17.39% year over year to ($0.38), which beat the estimate of ($0.55).

Revenue of $19,590,000 higher by 72.86% from the same period last year, which beat the estimate of $14,690,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

ShockWave Medical hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Nov 09, 2020

Time: 04:30 PM

ET Webcast URL:

Recent Stock Performance

Company's 52-week high was at $79.74

52-week low: $22.01

Price action over last quarter: Up 56.79%

Company Profile

ShockWave Medical Inc a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States.


Related Articles (SWAV)

View Comments and Join the Discussion!

Posted-In: Earnings